Syndax Pharmaceuticals , a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback